Studies: Adding ketamine does not help cancer pain

10/16/2012 | Medscape (free registration)

A late-stage clinical trial found that adding subcutaneous ketamine to opioids and standard coanalgesics did not improve control of cancer pain compared with a placebo, Flinders University researchers told a palliative care conference. The incidence of worsening adverse events, however, was nearly doubled among patients using ketamine compared with the placebo.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN